Search
Benzocaine
go.drugbank.com/drugs/DB01086ApprovedInvestigational[A231219] It is commonly used for local anesthesia in many over the counter products.[L32454,L32459,L32464] Benzocaine was first used for local anesthesia in dentistry.[A231259] … Benzocaine is an ester local anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings.
Mixtures: Chloraseptic Max, Gouttes Pour Mal D'oreillesCategories: Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use, Anesthetics for Topical UseMethyl salicylate
go.drugbank.com/drugs/DB09543ApprovedInvestigationalVet approvedMethyl salicylate (oil of wintergreen or wintergreen oil) is an organic ester naturally produced by many species of plants, particularly wintergreens. … For acute joint and muscular pain, methyl salicylate is used as a rubefacient and analgesic in deep heating liniments.
Mixtures: Hysan Hua Tuo Huo Lu, HO YAN HOR MEDICATED OILProducts: Hysan Hua Tuo Medicated, Zims Max HeatAllantoin
go.drugbank.com/drugs/DB11100ApprovedInvestigationalIn healthy human volunteers, the mean plasma concentration of allantoin is about 2-3 mg/l.
Mixtures: Kaewoon for Men, BEYOND THE SHAVE For MenProducts: Bodyglide For Her, U-max Multi BBGlycerin
go.drugbank.com/drugs/DB09462ApprovedInvestigationalA trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Mixtures: Chloraseptic Sore Throat Max, Chloraseptic Sore Throat MaxCategories: Drugs for Constipation, Cytochrome P-450 CYP2E1 InducersGuaifenesin
go.drugbank.com/drugs/DB00874ApprovedInvestigationalVet approvedcan reliably mitigate coughing. … After the negotiation between FDA and major manufacturers, a voluntary transition of labels for not using guaifenesin in children under the age of 4 years was endorsed by FDA in 2008 [F4525].
Mixtures: Maxi-Tuss PE Max, Only For COUGHProducts: expectorant 12 Hour, Mucus ER MaxOlodaterol
go.drugbank.com/drugs/DB09080ApprovedInvestigationalActivation of the receptor stimulates an associated G protein which then activates adenylate cyclase, catalyzing the formation of cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA). … Despite similarities in symptoms, olodaterol is not indicated for the treatment of acute exacerbations of COPD or for the treatment of asthma.
Mixtures: Spiolto Respimat 2,5 Mikrogramm/2,5 Mikrogramm Lösung zur Inhalation, Yanimo Respimat 2,5 Mikrogramm/2,5 Mikrogramm Lösung zur InhalationCategories: Drugs for Obstructive Airway Diseases, Cytochrome P-450 SubstratesMonopotassium phosphate
go.drugbank.com/drugs/DB09413ApprovedInvestigationalVet approvedIt can be used in fertilizer mixtures to reduce escape of ammonia by keeping pH low. … Monopotassium phosphate, MKP, (also potassium dihydrogenphosphate, KDP, or monobasic potassium phosphate), KH2PO4, is a soluble salt of potassium and the dihydrogen phosphate ion.
Mixtures: Nutriflex Peri Solution for Infusion, Isolyte S pH 7.4Products: INJECSOL KDP (Potassium Dihydrogen Phosphate 13.6% w/v Concentrated Injection BP)Fentanyl
go.drugbank.com/drugs/DB00813ApprovedIllicitInvestigationalVet approvedFentanyl, a potent opioid agonist, was developed in the 1950s to fill a need for strong and rapid analgesia. … [L6748] Opioid overdoses kill an average of 11 Canadians daily.[L6751] Fentanyl was FDA approved in 1968.[Label,L6598,L6601,L6604,L6607,L922,L6610,L6613]
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesProducts: Pat-fentanyl Mat, FENTANYL HEXAL MAT 12UG/HPyrithione
go.drugbank.com/drugs/DB06815ApprovedInvestigationalDandruff is a common scalp disease affecting >40% of the world's adult population, and may be caused by fungi such as _Malassezia globosa_ and _M. restricta_ [A32162]. … While its use has been approved in the early 1960's by the FDA [A32163], safety and effectiveness of pyrithione zinc has been reported for decades.
Mixtures: ReEn Mogangbichaek for Sensitive Scalp, ReEn Hairloss Clinic Jahajin Shampoo for Sensitive ScalpProducts: Pert Plus for Men Daily Dandruff, Every Man Jack 2-IN-1 Anti-dandruffBimatoprost
go.drugbank.com/drugs/DB00905ApprovedInvestigational[L6910] It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug
Mixtures: GANFORT PF, GANFORT PF Eye DropsCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates